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Abstract 
 
The preparation of hydrogels and stable emulsions is important in the formulation of many 
functional nanostructured soft materials. We investigate the multi-functional self-assembly and 
bioactivity properties of a novel surfactant-like peptide that shows antimicrobial activity, that 
is able to form hydrogels without pH adjustment, and is able to stabilize oil-in-water emulsions. 
Furthermore, we demonstrate on-demand de-emulsification in response to the protease enzyme 
elastase. We show that the surfactant-like peptide (Ala)9-Arg (A9R) forms -sheet fibers above 
a critical aggregation concentration and that water-in-oil emulsions are stabilized by a coating 
of -sheet fibers around the emulsion droplets. Furthermore, we demonstrate enzyme-
responsive de-emulsification, which has potential in the development of responsive release 
systems. The peptide shows selective antimicrobial activity against Gram negative pathogens 
including Pseudomonas aeruginosa, which causes serious infections. Our results highlight the 
utility of surfactant-like peptides in the stabilization of oil/water emulsions and the potential 
for these to be used to formulate antimicrobial peptide emulsions which are additionally 
responsive to protease. The peptide A9R has pronounced antibacterial activity against clinically 
challenging pathogens, and its ability to form -sheet fibers plays a key role in its diverse 
structural properties, ranging from hydrogel formation to emulsion stabilization. 
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Introduction 
 
The global healthcare challenge of emerging antimicrobial resistance is stimulating intense 
research activity into the development of new antimicrobial agents. Peptides (and biomaterials 
incorporating peptide motifs) are attracting considerable attention in several respects. Firstly, 
powerful antimicrobial peptides have already been evolved in nature and if these show 
antimicrobial activity whilst having minimal toxicity to human cells, such peptides can be used 
directly as antimicrobial agents. Alternatively, they may be used as a basis to design and screen 
related compounds. Smaller de novo designed peptides also show promise and are simple to 
synthesize in high purity. These peptides typically contain cationic residues such as arginine 
or lysine or the aromatic residue tryptophan.1-10 Surfactant-like peptides (SLPs) are a class of 
peptide with sequences of uncharged residues capped with charged residues, examples include 
peptides with alanine repeats capped with charged residues such as lysine, arginine, aspartic 
acid or glutamic acid.11-14 The amphiphilic properties of SLPs lead to self-assembly into 
distinct nanostructures in aqueous solution depending on the SLP sequence and the solution 
conditions. 2, 11-29 SLPs are a potentially valuable class of peptide antibacterial agents because 
the self-assembled structure can lead to high density presentation of the active motif (i.e. the 
sequence of charged residues in the case of antimicrobial SLPs).  
Our group has been studying the self-assembly of SLPs and has recently begun to investigate 
their potentially valuable bioactivities. The SLP NH2-A6R-OH (A6R) self-assembles into 3 nm- 
thick nanotapes at low concentration but at high concentration these wrap into helical ribbon 
and nanotube structures.23 The interaction of this peptide with model zwitterionic lipid 
membranes (1,2-dipalmitoyl-sn-glycero-3-phosphocholine, DPPC) was examined. The 
interaction leads to loss of peptide -sheet conformation and restructuring of the lipid 
membrane (from multilamellar to unilamellar) but not membrane lysis.30 In the same paper, a 
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preliminary study of antimicrobial activity showed activity against Gram positive 
Staphylococcus aureus.30 More recently, the self-assembly and antimicrobial properties of A6R 
with free termini and capped termini  has been investigated.31 The capped variant, CH3CONH-
A6R-NH2, forms nanofibrils whereas the uncapped peptide NH2-A6R-OH assembles into 
nanotapes. From measurements of lamellar spacings, small-angle X-ray scattering (SAXS) 
showed the selective interaction of the capped peptide with the anionic lipid POPG [2-oleoyl-
1-palmitoyl-sn-glycero-3-phospho-rac-(1-glycerol)] in mixed POPG/POPE [POPE: 2-oleoyl-
1-palmitoyl-sn-glycero-3-phosphoethanolamine] anionic/zwitterionic vesicles. The capped 
peptide also showed selective activity against gram positive Listeria monocytogenes, the 
uncapped version showed greater antimicrobial activity against S. aureus, L. monocytogenes, 
and E. coli.31  
An alternative design of SLP has charged residues at both termini (“triblock polymer”-like 
architecture or bola-amphiphile structure). The self-assembly of SLPs including I2K2I2 and 
KI4K were investigated and the sequence change was found to profoundly influence 
aggregation since the former shows no defined nanostructure (and there is no evidence for -
sheet formation) whereas the latter forms nanotubes based on -sheet hydrogen bonding.25, 32 
The bolaamphiphile RFL4FR self-assembles into nanosheets and nanotubes and its 
compatibility with fibroblast cells was demonstrated.33  This peptide forms a shear-aligned 
nematic phase of nanotubes.34 The SLP RA3R adopts a polyproline II conformation in water.
35 
The peptide interacts strongly with POPG in mixed POPG/POPE vesicles leading to enhanced 
correlation of lipid bilayers in liposomes, but in contrast, the interaction of RA3R with 
multilamellar POPC/DOPC [POPC: 1-palmitoyl-2-oleoyl-sn-glycero-3-phosphocholine, 
DOPC: 1,2-Dioleoyl-sn-glycero-3-phosphocholine] vesicles leads to the de-correlation of the 
lipid bilayers. RA3R was found to be particularly active against L.monocytogenes through a 
proposed mechanism of membrane reorganisation.35  
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Building on our recent work on alanine/arginine SLPs, in the present paper we first investigate 
the self-assembly and antimicrobial activity of the SLP A9R before investigating whether such 
a surfactant-like peptide can be used to stabilize an oil/water emulsion. We hypothesized that 
increasing the length of the alanine sequence would favourably alter the amphiphilicity of the 
molecule compared to A6R. To the best of our knowledge, emulsion formation by surfactant-
like peptides has not previously been considered, and we also examine the mechanism behind 
the observed stabilization. Peptide A9R has a longer alanine sequence and is thus more 
hydrophobic than both A6R and RA3R. However, remarkably even just the single cationic 
arginine is sufficient to enable solubility in aqueous solution and self-assembly behaviour. The 
conformation of the peptide is probed using circular dichroism spectroscopy. The presence of 
a critical aggregation concentration is assayed through fluorescence probe measurements. The 
nature and structure of the self-assembled nanostructures are then investigated using SAXS, 
cryogenic transmission electron microscopy (cryo-TEM) and X-ray diffraction. Unexpectedly, 
the peptide is observed to form a self-supporting hydrogel at sufficiently high concentration 
without pH adjustment, a feature not previously reported for this type of SLP, and the 
rheological properties of the gel are measured. Since long alanine repeats are known substrates 
for the enzyme elastase (which plays an important role in remodelling the extracellular matrix), 
we also investigate the elastase-induced degradation of the peptide, inspired by our work on 
related SLP KA6E.
36  
It has been suggested that the multivalent display of the active group (here arginine) in self-
assembled structures can enhance bioactivity, as exemplified for example by studies on 
lipopeptides containing cationic residues.37 Futhermore, the antibacterial activity of peptides is 
generally due to physical disruption of bacterial membranes which may reduce the 
development of antimicrobial resistance.38 The disruption of membranes may be enhanced by 
peptide self-assembly. Related to peptide A9R, it has been shown that peptide A9K, which 
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forms fibrils has marked antimicrobial activity against E. coli and S. aureus, and in fact this is 
stronger than for the homologues A3K and A6K at a given concentration.
17 It has recently been 
shown that peptide A9K2 forms fibrillary hydrogels and these have antimicrobial activity.
38 
Here, we assayed the antimicrobial activity, and cytocompatibility (using model human 
fibroblast cells) of A9R. The combination of antimicrobial activity (and cytocompatibility with 
human cells) along with the degradability of the peptide in the presence of an essential 
extracellular matrix enzyme points to potential utility of the SLP A9R in the development of a 
wound healing biomaterial.  
Emulsions offer a potentially powerful route to stabilize formulations of active peptides or to 
create emulsions stabilized by bio-compatible, bio-functional or bio-responsive peptides. 
These systems are less well understood than protein-stabilized emulsions where proteins serve 
as Pickering stabilizers, acting as particles that reduce interfacial tension at the oil/water 
interface.39-41 Recently, Ulijn’s group has shown that Fmoc-dipeptides can stabilize 
chloroform-in-water emulsions due to the formation of a peptide layer at the droplet surface 
stabilized by -stacking and H-bonding of peptides.42  In addition, this group has shown that 
tripeptides (with a propensity to aggregate assessed from a screen of all 203= 8000 tripeptides 
containing native residues) stabilize oil/water emulsions, in some cases by forming nanofibrous 
networks.43 In addition, the self-assembly of the peptide can be triggered by biocatalysis using 
an enzyme to dephosphorylate a precursor to produce a hydrogelating peptide.44 Here, we show 
that a distinct class of peptide, i.e. a surfactant-like peptide such as A9R can be formulated into 
an emulsion where it acts as a stabilizer at the oil/water interface due to the formation of a 
coating of -sheet fibrils. Finally, we demonstrate on demand de-emulsification induced by the 
catalytic activity of elastase on A9R emulsions. 
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Experimental 
Materials. Peptide A9R was supplied by Biomatik (Cambridge, Ontario, Canada). The purity 
was 98.93% by HPLC using an Inertsil ODS-SP column with acetonitrile (0.1% TFA)/water 
(0.1% TFA) gradient. The molar mass by ESI-MS was 814.90 gmol-1 (M+H+, 813.92 g mol-1 
expected). Scheme S1 shows the chemical structure of A9R. Elastase from porcine pancreas 
(MW= 25.9 kDa) and Trizma
@ base were purchased from Sigma-Aldrich.  1-bromohexadecane 
was purchased from Sigma-Aldrich. Lipids DOPC, POPC, POPG and POPE were obtained 
from Sigma-Aldrich. 
A9R dissolved as a substrate for elastase. Elastase solubility and enzymatic activity increases 
at pH 8. Weighed amounts of A9R or elastase were dissolved in a Trizma
@ base solution 
(titrated with 1 M HCl to pH 8) to evaluate the enzymatic activity of elastase on A9R. The 
molar ratio of A9R to elastase is indicated as [A9R]/ [elastase]= Mre ([]: molar concentration). 
Vesicle preparation. Vesicles were prepared by the thin layer hydration method, as reported in 
the literature for hybrid POPE/POPG vesicles.45 Measured quantities of lipids were dissolved 
in chloroform, dried under a stream of nitrogen and placed in a vacuum chamber for 2 hrs in 
order to remove traces of organic solvent.   The lipid film was then re-suspended in a weighed 
quantity of water to obtain 0.5 wt% lipid, vortexed at 1800 rpm at 55 oC for 5 minutes and left 
to equilibrate before experiments. Anionic POPG/POPE vesicles were made to provide a POPG 
molar fraction POPG = [POPG]/([POPG]+[POPE]) = 0.2 (here [ ] refers to the molar 
concentration)  which corresponds to a POPG/POPE content 27/73 wt%. Zwitterionic vesicles 
were made by mixing POPC and DOPC lipids at a fixed molar fraction of DOPC, DOPC= 
[DOPC]/([POPC]+[DOPC]) = 0.2 which corresponds to POPC/DOPC content of 80/20 wt%. 
The ratios 27/73 and 80/20 are calculated from the weight of each lipid used to prepare the 
vesicles. The vesicles, containing POPG or DOPC, were always prepared with a fixed total 0.5 
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wt% lipid concentration in the aqueous dispersion.  For mixed peptide-lipid samples, a weighed 
quantity of A9R powder was added to solutions containing the lipid vesicles described above, 
to obtain 0.08 wt% A9R. The mixtures were then vortexed at 1800 rpm and 55 
oC for 5 minutes 
and left to equilibrate before experiments.  
A9R emulsion preparation. Emulsions were prepared by mixing measured volumes of 1-
bromohexadecane (density 1 g ml-1) with aqueous solutions of A9R. This oil was chosen to 
match the density of both phases in order to reduce possible spontaneous de-emulsification 
process.46 Preliminary tests were performed to investigate the time stability of emulsions 
containing a range of different volume ratios of water/1-bromohexadecane emulsions stabilised 
by 0.05 wt % A9R. Visual inspection revealed emulsions containing 30/70 v/v water/1-
bromohexadecane were the most stable. Such emulsions were made by vigorously stirring 300 
l of 0.16 wt% A9R in water with 700 l of 1-bromohexadecane, to obtain a final 0.05 wt% 
A9R concentration calculated with respect to the total mass of liquid. In the following, we will 
refer to 0.05 wt% A9R in water/1-bromohexadecane 30/70 v/v emulsion simply as a 0.05 wt% 
A9R emulsion.  
Fluorescence Assays. Samples were placed inside a quartz cell with 10.0 × 5.0 mm2 internal 
cross section, and the fluorescence was measured using a Varian Cary Eclipse 
spectrofluorimeter. The critical aggregation concentration (cac) was determined via Thioflavin 
T (ThT) or pyrene (Pyr) fluorescence experiments. The thioflavin T (ThT) fluorescence assay 
was performed to detect amyloid formation, since it is well-known that ThT fluorescence 
depends on the formation of amyloid-like structures (-sheet fibrils).47-48  For the ThT assay, 
emission spectra were recorded from 460 to 600 nm using an excitation wavelength ex= 440 
nm, for peptide solutions containing 5.0×10-3 wt % ThT.  
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The Pyr assay was performed to identify the formation of a hydrophobic environment by the 
peptide, to provide complementary information to the ThT assay. A solution containing 1.3 × 
10−5 M Pyr in water was used to dilute peptide solutions within the ranges (1.3× 10−3- 0.13) wt 
% A9R. The fluorescence of Pyr was excited at 335 nm at room temperature, and the emission 
spectra were recorded from 360 to 460 nm. 
Fluorescamine (FLC) reacts with primary amines to form fluorescent products. Therefore, a 
FLC assay was used to detect the formation of primary amines due to the cleavage of A9R by 
elastase. Solutions containing 1x10-3-5x10-2 wt% A9R, at Mre= [A9R]/[elastase]~ 3-158, were 
prepared using 0.07 wt% FLC as a solvent in Trizma® base solution (pH 8). The samples were 
excited at ex= 380 nm, and the fluorescence emission was measured for = (410-600) nm.  
Circular Dichroism (CD) Spectroscopy. CD spectra were recorded using a Chirascan 
spectropolarimeter (Applied Photophysics, UK). Solutions were placed in a quartz cover slip 
cuvette (0.01 mm thick). Spectra are presented for absorbance A < 2 at any measured point 
with a 0.5 nm step, 1 nm bandwidth, and 1 s collection time per step. The CD signal from the 
water background was subtracted from the CD data of the sample solutions. 
Fourier Transform Infra-Red (FTIR) Spectroscopy. Spectra were recorded using a Nexus-
FTIR spectrometer equipped with a DTGS detector. Samples were measured using an ATR 
configuration with a PEARL liquid cell. Spectra were scanned 128 times over the range of 900-
4000 cm-1. 
X-ray Diffraction (XRD). Measurements were performed on stalks prepared by drying a drop 
of solution suspended between the ends of wax-coated capillaries. The stalks were mounted 
onto a four axis goniometer of an Oxford Diffraction Gemini Ultra instrument. The sample-
detector distance was 44 mm. The X-ray wavelength λ = 1.54 Å was used to calculate the 
scattering vector q = 4πsin/λ (2 scattering angle). The detector was a Sapphire CCD. 
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Transmission Electron Microscopy (TEM). TEM imaging was performed using a JEOL 
2100Plus TEM microscope operated at 200 kV. Droplets of A9R emulsion was placed on Cu 
grids coated with a carbon film (Agar Scientific, UK), stained with uranyl acetate acid (1 wt 
%) (Sigma-Aldrich, UK) and dried. 
Cryogenic-Transmission Electron Microscopy (Cryo-TEM). Imaging was carried out using a 
field emission cryo-electron microscope (JEOL JEM-3200FSC), operating at 200 kV. Images 
were taken in bright field mode and using zero loss energy filtering (omega type) with a slit 
width of 20 eV. Micrographs were recorded using a Gatan Ultrascan 4000 CCD camera. The 
specimen temperature was maintained at -187 oC during the imaging. Vitrified specimens were 
prepared using an automated FEI Vitrobot device using Quantifoil 3.5/1 holey carbon copper 
grids with a hole size of 3.5 m. Just prior to use, grids were plasma cleaned using a Gatan 
Solarus 9500 plasma cleaner and then transferred into the environmental chamber of a FEI 
Vitrobot at room temperature and 100 % humidity. Thereafter 3 l of sample solution was 
applied on the grid and it was blotted twice for 5 seconds and then vitrified in a 1/1 mixture of 
liquid ethane and propane at temperature of -180 °C. The grids with vitrified sample solution 
were maintained at liquid nitrogen temperature and then cryo-transferred to the microscope. 
Cryogenic-Scanning Electron microscopy (cryo-SEM). Imaging was performed using an FEI 
Quanta 600F instrument in high vacuum mode.  Samples were mounted onto aluminium stubs 
and frozen in liquid nitrogen slush at approximately -210 °C.  Once frozen, samples were 
transferred under high vacuum to a sample preparation chamber and allowed to equilibrate to 
the appropriate temperature prior to fracturing.  Solutions were fractured at -185 °C and 
allowed to sublime at -90 °C for approximately 20 minutes.  The temperature was then reset to 
-135 °C in the preparation chamber and the sample coated with a thin layer of platinum for 80 
seconds, prior to imaging at 12.5 kV. 
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Small-Angle X-Ray Scattering. Synchrotron SAXS experiments on solutions were performed 
using a BioSAXS robots on beamline BM29 (ESRF, France), and on beamline B21 (Diamond 
Light Source Ltd., UK). On beamlines BM29 and B21, solutions were loaded into the 96 well 
plate of an EMBL BioSAXS robot, and then injected via an automated sample exchanger into 
a quartz capillary (1.8 mm internal diameter) in the X-ray beam. The quartz capillary was 
enclosed in a vacuum chamber, in order to avoid air scattering. After the sample was injected 
in the capillary and reached the X-ray beam, the flow was stopped during the SAXS data 
acquisition. B21 operated with a fixed camera length (3.9 m) and fixed wavelength  = 1 
Å.  The images were captured using a PILATUS 2M detector. Data processing (background 
subtraction, radial averaging) was performed using the dedicated beamline software ScÅtter. 
BM29 operated with an X-ray wavelength  = 1.03 Å.  The images were captured using a 
PILATUS 1M detector, while data processing was performed using dedicated beamline 
software ISPyB.  
Synchrotron SAXS and wide angle X-ray scattering (WAXS) on gels were performed on 
BM26B (ESRF, France). The peptide gels were introduced in DSC pans with mica windows 
to enable transmission of the X-ray beam. The distance to the 2D multiwire SAXS detector 
was ca. 5 m using a wavelength of 1.45 Å WAXS images were recorded using a CCD-based 
X-ray digital camera (Photonic science).. 
Rheology. Rheological properties were determined using a controlled stress TA Instruments 
AR-2000 rheometer (TA Instruments). The experiments to characterise A9R gels were 
performed using a cone-and-plate geometry (cone radius= 20 cm; cone angle= 1o). The linear 
regime was first determined performing stress sweep experiments in the range (0.08 - 1000) Pa 
at a constant angular frequency of 6.28 rad/s. Frequency sweep experiments were performed a 
constant stress within the linear regime, and angular frequencies between 0.1 and 627 rad/s. 
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The viscosity of the A9R emulsions was measured performing controlled stress experiments 
with a cone-and-plate geometry (cone radius= 40 cm; cone angle= 1o) and shear stress between 
0.05 and 23 Pa.  
Electrospray-ionization Mass Spectroscopy (ESI-MS). Electrospray-ionization mass spectra 
were recorded using a Thermofisher Obitrap XL instrument. Samples, which were presented 
as 1 mg/ml, were diluted 33 fold (30 L sample + 970 L MeOH). The two LCMS mobile 
phase buffers (water and acetonitrile) included 0.1% formic acid to assist the reverse phase 
separation and to aid protonation.  
Polarized Optical Microscopy (POM). Images were obtained with an Olympus BX41 
polarized microscope by placing the sample between crossed polarizers. Samples were placed 
between a glass slide and a coverslip before capturing the images with a Canon G2 digital 
camera.  
Laser Scanning Confocal microscopy (LSCM). Experiments were performed on a Nikon A1-
R plus confocal microscope, using an objective Plan Apo VC DIC N2 with a 20x magnification 
and a numerical aperture 0.75. For LSCM, A9R emulsion was prepared by vigorously stirring 
300 l of 0.16 wt% A9R, dissolved in 5x10-3 wt% ThT, with 700 l of 1-bromohexadecane. 
The excitation wavelength generated by an Argon laser was 488 nm, while the emission 
detection was in the range 525 nm. Data was collected with a pinhole radius 17.88. Samples 
were put between a glass slide and a coverslip. 
Cytotoxicity assays. The cytotoxicity of A9R was examined using an MTT 3-(4,5-
dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide) assay. In vitro cell culture was 
conducted using the human skin fibroblast cell line, 161Br (European Collection of 
Authenticated Cell Cultures, ECACC) cells. Cells were cultured in EMEM, with 2 mM 
glutamine, enriched with 15% fetal bovine serum (FBS) and 1% non-essential amino acids 
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(NEAA) and 1% antimycotic-antibiotic. Cells were maintained in a humidified atmosphere at  
37 oC and 5% CO2. 
 For the MTT assay, cells were seeded into a 96-well plate at a concentration of 4x104 cells/mL, 
and were allowed to adhere for 24 hours in 100 µL of complete medium. The peptide was 
dissolved in complete medium, and added to the cells to give a final volume of 200 µL at 
concentrations between 0.005 and 0.5 wt% A9R. One well, containing 200 µL of complete 
medium with no peptide, was used as a control. Then, the fibroblasts were incubated for 67 
hours. After this, 20 µL MTT (5 mg/ mL, in PBS) was added to each well plate and allowed to 
incubate for 5 hours (72 hours total). Following the incubation time, the solution was removed 
from the wells and replaced with 100 µL DMSO per well to dissolve the formazan crystals. 
Plates were incubated for 30 minutes, and then analysed using a UV microplate reader (λ=570 
nm). Results are reported as a % cell viability compared to control (untreated) values. ANOVA 
and Bonferroni post hoc tests were used to assess statistical significance.  
Antimicrobial assays. The antimicrobial assays were performed with 3 strains of bacteria, S. 
aureus SH1000, E. coli K12 MG1655 and P. aeruginosa PA01. Stock cultures were stored in 
20% glycerol at -80 oC.  Prior to experiments all three strains were streaked out onto LB 
(Lysogeny Broth) agar and grown overnight at 37oC. From these plates, one colony was then 
transferred into 3mL sterile tryptone soy broth (TBS) supplemented with 0.3 % (w/v) yeast 
extract, and grown at 37 oC under agitation at 150 rev/min, on an orbital shaker overnight and 
these cultures were used for ongoing experiments. Cultures were then transferred into a 15 ml 
falcon tube and cells were harvested by centrifugation at 9000 rpm and 4oC for 10 minutes. 
The supernatant was discarded and the pellet was resuspended in 1.5 mL ice chilled PBS 
(phosphate buffered saline). After this, 30 μL of this solution was transferred into 300 μL of 
0.05 wt% A9R in sterile water or control solutions of 300 μL of sterile water. Solutions were 
then vortexed for 5 seconds and 3 x 20μL aliquots were taken at times 0, 30, 60, 120 and 1440 
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minutes. These samples were then serially diluted in PBS, and 10 μL of each dilution was 
platted onto LB agar and incubated at 37 oC overnight before colony counting.  
 
Results and Discussion  
We first examined the self-assembly of A9R in water, including potential hydrogel formation, 
together with the interaction of A9R with model membranes simulating mammalian or 
microbial cell walls. We then investigate the degradation and de-fibrillization of A9R by 
cleavage of the oligoalanine sequence through elastase proteolysis. The cytotoxicity and 
antimicrobial activity of A9R is then investigated and the results are understood in terms of the 
interaction of the peptide with model lipid membranes mimicking the membranes of bacterial 
and mammalian cells.  Finally, we report a method to prepare peptide emulsions as a novel 
method to deliver A9R at a non-toxic and antimicrobially active concentration. In addition, we 
show that the catalytic activity of elastase on A9R can be used as a route for de-emulsification.  
Self-assembly in water and interaction with model biological membranes. We investigated 
the self-assembly of A9R in water, performing fluorescence spectroscopy assays and CD, FTIR, 
XRD, SAXS, WAXS, cryo-TEM and rheology experiments. The results are summarized in 
Figure 1 and Figure 2. The pKa of A9R is estimated to be approximately 11,
49 and the charge 
is +1 in aqueous solution. 
Fluorescence assays using the dye ThT were performed to determine the critical aggregation 
concentration (cac) for amyloid formation by A9R. Figure 1a shows the fluorescence emission 
intensity of ThT at 486 nm for solutions containing A9R (I), normalized by the fluorescence 
emission intensity of ThT at 486 nm for solutions without A9R (Io). A discontinuity in I/Io as a 
function of A9R concentration shows that the peptide forms amyloid fibrils at concentrations 
equal or higher than cac = (0.05 ± 0.01) wt% A9R (Figure 1a), which may be compared with a 
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cac = 1.4 wt% for the related peptide A6R previously reported by us.
23 The lower cac for A9R 
is consistent with the increase in the hydrophobicity of the peptide as a result of a longer alanine 
sequence. 
Fluorescence assays using the dye pyrene (Pyr) were performed to determine the concentration 
for the formation of a hydrophobic environment by A9R peptide, and therefore provide 
complementary information to the ThT assay. Figure S1 shows the fluorescence emission 
intensity of Pyr at 373 nm for solutions containing A9R (I1), normalized by the fluorescence 
emission intensity of Pyr at 373 nm for solutions without A9R (I0,1). According to data in Figure 
S1, A9R self-assembles into a structure with a hydrophobic core for concentrations equal or 
higher than (0.07 ± 0.01) wt% A9R (Figure 1a). This is the same as the cac determined from 
ThT fluorescence within respective uncertainties, and indicates that the formation of -sheet 
fibrils occurs at the same concentration as sequestration of the hydrophobic alanine residues 
into the fibril cores. 
 The CD spectra for A9R (Figure 1b), show a maximum at 194 nm and a minimum at 217 nm, 
corresponding to a -sheet structure over the concentration range 0.08 – 1 wt% A9R.50  The 
FTIR spectra for A9R in Figure 1c (for the same concentration range) show FTIR bands centred 
at 1626 and 1698 cm-1, which confirms the -sheet structure of the self-assembled peptide.51 
The peak at 1672 cm-1 is due to bound TFA counterions.52-54 These results confirm the retention 
of -sheet structure over a wide concentration range above the cac. 
Figure 1d shows a cryo-TEM image of a sample containing 1 wt% A9R. The image shows the 
formation of long fibers, ~ 5 nm in diameter. Figure 1e shows the SAXS data measured for 
0.08 and 1 wt% A9R (data for samples with 0.5 wt% and 9.5 wt% A9R are shown in Fig.S3 and 
Fig.2c respectively), along with model form factor fits using a long cylindrical shell model, 
performed with the software SASfit.55 The parameters of the model are the core radius R (with 
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polydispersity R), the shell thickness Dr and the scattering length density of the core, shell 
and solvent core, shell and solv.  The parameters extracted from the fitting are listed in Table 
S1. The parameters obtained from the SAXS fittings for 0.08-1 wt% sample are consistent. In 
particular, at 1 wt% A9R, R ± R = (20.3±10.8) Å and Dr = 3 Å, indicate that the cylinder core 
radius is smaller than the length of the oligoalanine A9 sequence= 28.8 Å (spacing per residue 
in a parallel -sheet is 3.2 Å56), while the external shell has a thickness very similar to the 
length of one arginine residue. This result shows that there is an overlapping of the alanine 
chains inthe core of the fibers, with the arginine residue exposed at the surface of the fibers. 
The fiber radius from SAXS is in good agreement with the dimensions obtained from cryo-
TEM images. 
We unexpectedly found that, even without pH adjustment, A9R forms a self-standing hydrogel 
at a higher peptide concentration in water (Figure 2a). Rheology experiments were performed 
to evaluate the viscoelastic properties of the hydrogel.  Stress sweeps show approximately 
linear viscoelastic behaviour up to a stress  = 20 Pa (Figure S2). Frequency sweeps at a fixed 
shear stress within the linear regime ( = 4.78 Pa), reveal a low frequency plateau in the moduli 
with G’ > G”, consistent with a gel-like response (Figure 2b). The XRD spectra for a peptide 
stalk dried from a 5 wt% A9R gel has peaks at 9, 5.3, 4.4, 3.7, 2.5, 2.2 and 2 Å (Figure 2c). 
Figure 2d shows the SAXS data measured for a 9.5 wt% A9R hydrogel, along with the fitting 
of the experimental data using a long cylindrical shell form factor model.  The parameters 
extracted from the fitting are listed in Table S1. The values, R ± R = (15.0±10) Å and Dr = 2 
Å, indicate that the hydrogel contains peptides fibers with similar dimensions to those in 
solution. The WAXS data for 9.5 wt% A9R hydrogel (Figure 2d), shows peaks at 5.4, 4.4, 3.2 
and 2.7 Å. Both XRD (Figure 2c) and WAXS (Figure 2d) data indicate a -sheet structure and 
are very similar to the XRD patterns already reported by us for 17 wt% A6R
23 and 1 wt% 
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capA6R.
31 In analogy with our previous XRD analysis of oligo-alanine SLPs,23, 31 we assign 
reflections in Figure 2d to the packing of the oligo-alanine -sheets (5.3 Å), and intra-sheet 
spacings (4.4, 3.7, 2.5, 2.2 and 2 Å). The -sheet spacing 5.3 Å is very small compared to 
typical amyloid structures because oligo-alanine sequences facilitate close packing of the 
peptide chains. In summary, we demonstrated that A9R forms -sheet fibrils above a critical 
aggregation concentration in water, and that the peptide is able to form self-supporting 
hydrogels. 
A9R degradation in response to elastase enzymatic activity. Having established that A9R self-
assembles into fibrils in solution, and since alanine is a substrate for elastase catalytic activity, 
we investigated the enzyme-induced degradation and de-fibrillisation of the peptide.  
Figure S3a shows the CD spectra for 0.5 wt% A9R compared to the CD spectra for 0.5 wt% 
A9R (Mre =158) after 3 and 68 hrs incubation. Similar results are displayed for 0.1 wt% A9R 
(Mre = 31) in Figure S3b. Samples studied at 68 hrs incubation were diluted and used for the 
FLC assay. The results are displayed in Figure S3c. The CD spectrum for 0.5 and 0.1 wt% A9R 
shows -sheet features, however these are eliminated upon incubation with elastase for 68 hrs, 
and a spectrum of a disordered peptide conformation is observed (Figure S3a,b). A FLC 
fluorescence assay was performed to confirm the existence of free amine groups in the solution. 
The emission fluorescence spectrum of the FLC was characterised by a broad maximum 
centred at 475 nm (results not shown). Figure S3c shows that the fluorescence emission at 475 
nm increases with Mre ratio. The results in Figure S3 are consistent with the degradation of the 
A9R fibrils by elastase. 
SAXS was used to investigate the structure of A9R fibers with and without elastase. Figure S4 
compares the SAXS data for a 0.5 wt% A9R solution and a solution containing elastase and the 
same concentration of A9R, after incubation at Mre =158 for 68 hrs. The SAXS data for 0.5 
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wt% A9R can be fitted using the form factor for a cylindrical shell (fitting parameters listed in 
Table S1). However the SAXS data shows the loss of the cylinder form factor shape due to the 
fibre fragmentation after exposure to the elastase.  
Finally, the effect of elastase on the peptide (0.1 wt% A9R, Mre = 31, 68 hrs incubation) was 
studied by ESI-MS. The mass spectra are displayed in Figure S5. The identification of different 
fragments of A9R in the ESI-MS spectra, together with the absence of a peak corresponding to 
the expected molecular weight of A9R, confirm the fragmentation of the peptide in response to 
elastase. We hypothesized that this could be exploited in enzyme-responsive de-emulsification 
(vide infra). 
A9R cytotoxicity and antimicrobial activity. To examine the cytocompatibility of A9R, the 
viability of the peptide was tested using 161Br skin fibroblast cells via MTT assays (Figure 
3a). Peptide A9R was tolerated by the cells up to a concentration of 0.05 wt% (~75% viability), 
which corresponds to the minimal concentration for amyloid fibril formation (cac; Figure 1a). 
A lower cell viability <70% was observed from 0.1 to 0.5 wt% A9R. The antimicrobial activity 
of the A9R peptide was studied using two model Gram negative microorganism, E. coli (K12) 
and P. aeruginosa and one Gram positive microorganism, S. aureus. Microorganisms were 
treated with 0.05 wt% A9R; the highest concentration for peptide viability. Preliminary tests 
were performed using 0.01 wt% A9R, but at that concentration no significant antimicrobial 
activity (results not shown) was observed. 
The antimicrobial assays of the activity of A9R against S. Aureus, E. coli (K12) and P. 
aeruginosa are displayed in Figure 3b-d. The effect of A9R on S. Aureus was not statistically 
significant (Figure 3b). However, a statistically significant antimicrobial effect was found with 
the E. coli (K12) and P. aeruginosa (Figure 3c,d). In particular, a major effect of a 4 order of 
magnitude reduction in CFU/ml was found with P. aeruginosa while a less pronounced effect 
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was seen with E. coli (K12). Overall, the data in Figure 3c,d shows a dramatic effect of A9R 
on the numbers of bacteria within the first 1-2 hrs. Subsequently the numbers of E. coli (K12) 
and P. aeruginosa remained stable up to 24 h.  
The results in Figure 3 suggest that A9R shows selective antimicrobial activity against Gram 
negative microorganisms, which cause infections that are particularly challenging to treat. In 
contrast, we previously reported that closely related peptides RA3R, A6R and capA6R have a 
major antimicrobial activity against the Gram positive bacteria L. monocytogenes.31, 35  
To examine the potential mode of antibacterial activity we studied the interaction of A9R with 
vesicles comprising lipid mixtures representing model bacterial membranes (POPG/POPE) or 
eukaryotic membranes (DOPC/POPC), using SAXS to probe the lipid bilayer stacking. These 
results provide insight into the mechanism of selective antimicrobial activity of A9R. We 
studied samples containing 0.08 wt% A9R because, although a relatively low concentration, 
that was the highest concentration of peptide which did not induce sample precipitation in the 
presence of the lipid vesicles. The lipid mixture composition was fixed with a mole fraction 
DOPC= 0.2 in the DOPC/POPC mixture or POPG= 0.2 in the POPG/POPE mixture. The peptide 
powder was dissolved in the solution of vesicles. The corresponding SAXS data is displayed 
in Figure S6. The SAXS data for the liposomes without peptide in Figure S6 was already 
reported by us,31, 35 and it is presented here only as a reference. The SAXS data for DOPC= 0.2 
displays two peaks in a positional ratio 1:2 corresponding to a lamellar spacing of 64.4 Å. The 
intensity of the lamellar peaks is reduced by the addition of 0.08 wt% A9R (Figure S6a). 
The SAXS data for the lipid vesicles with POPG= 0.2 (Figure S6b) shows a broad peak centred 
at ~0.1 Å arising from a single bilayer form factor.31, 35, 45 Addition of 0.08 wt% A9R induces 
the formation of multilamellar ordering with a bilayer spacing d= 88.4 Å.  
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The SAXS data in Figure S6 was further analysed using models for the form factor and 
structure factor of a lamellar structure. Details of the model57 are provided in the 
Supplementary Information. Fits to the SAXS data are displayed in Figure S6, while the 
parameters extracted from the fitting are listed in Table S2.  
Addition of 0.08 wt% A9R to DOPC=0.2 vesicles changes the bilayer structure by decreasing 
the distance between headgroups (lH), increasing the thickness of the water layer (lw) and 
reducing the correlation between bilayers (N) (Table S2). Accordingly, A9R is not inserted in 
the DOPC/POPC bilayers, but decorates the surface of those bilayers as previously reported by 
us for the study of the interaction of A6R with zwitterionic multilamellar vesicles.
30 Addition 
of 0.08 wt% A9R to POPG=0.2 vesicles induces the correlation of lipid bilayers (N) and 
increases the distance between headgroups (lH) suggesting the insertion of A9R in the lipid 
bilayers (Table S2). 
These findings are significant in terms of the possible mode of antimicrobial activity of A9R. 
Several mechanisms have been proposed by which bacterial cell membranes are restructured, 
involving different modes of incorporation of peptides into the lipid membrane (to form pores 
as in the barrel-stave model) or adsorption onto the surface of the membrane (carpet model) 
with subsequent membrane break up or the formation of toroidal pores due to peptide-induced 
lipid curvature.3, 5, 8, 58 A9R appears to restructure bacterial cell membrane-mimicking 
POPG=0.2 vesicles by inserting into the lipid membrane due to electrostatic attraction, which 
induces a correlation between bilayers. In contrast, A9R does not insert in the zwitterionic 
membrane -mimicking DOPC=0.2 vesicles, which may underlie the low observed cytotoxicity.   
A9R emulsification. We investigated the ability of A9R to stabilize emulsions containing 0.05 
wt% A9R; a dosage of peptide that allows for cell viability but is simultaneously effective 
against E. coli (K12) and P. aeruginosa. The stability of 0.05 wt% A9R emulsion was checked 
through its physical appearance a few minutes and 3 days after emulsification (Figure S7). 
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After one day of mixing, phase separation occurs in the mixture without the peptide, which 
becomes more visible after 3 days of mixing (Figure S7b,d). In contrast, the peptide stabilises 
the emulsion and no phase separation is observed even after 3 days of mixing (Figure S7a,c). 
The emulsion shows shear-thinning behaviour (Figure S8) with a limiting viscosity ~ 19 mPa.s, 
significantly higher than the viscosity of the water (0.89 mPa.s at 25 oC).59 
The structure of the 0.05 wt% A9R emulsion was studied by a range of microscopy techniques. 
Results obtained using POM, LSCM and TEM are displayed in Figure 4. Polarized optical 
microscopy images (Figure 4a,b) show that the peptide stabilizes the emulsion through the 
formation of micrometer-size droplets with irregular shape. LSCM was used to assess the 
presence of peptide fibrils within a 0.05 wt% A9R emulsion prepared with A9R fibers stained 
with ThT, since ThT is known to bind to amyloid fibers.47 LSCM images (Figure 4c,d) show 
that the fluorescent peptide fibers are adsorbed at the surface of the droplets making a ~ 1 m 
thick layer.  TEM was used to confirm that the peptide fibers stabilized at the surface of the 
droplets in the emulsion are ~ 25 nm in diameter (Figure 4e). The CD spectra in Figure 4f show 
that the population of -sheets is higher for A9R fibers in the emulsion than for a peptide 
solution with the same peptide concentration in the aqueous phase. The combination of images 
and CD data in Figure 4 clearly shows that the emulsion is stabilized by A9R fibers adsorbed 
at the surface of the droplets. These fibers form a micron- thick layer on the surface of the 
droplets. This appears to indicate an unexpected inverse Pickering-type emulsion stabilization 
mechanism by peptide fibers, rather than simple interfacial adsorption of the surfactant-like 
peptide molecules. The fibers are assembled from peptides with amphiphilic character and it is 
expected that the hydrophilic arginine residues will be exposed to the aqueous phase. 
Figure 5 shows cryo-SEM images obtained for 0.05 wt% A9R emulsion. The images show 
droplets on the micrometer length scale, wrapped by a network of fibers. This result is in good 
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agreement with LSCM images in Figures 4c-d showing the absorption of A9R peptide fibers at 
the surface of the droplets in the emulsion.   
As a further development towards a multi-functional responsive peptide biomaterial, we 
examined de-emulsification driven by the elastase–induced degradation of the A9R fibers. 
The 0.05 wt% A9R emulsion, stained with ThT and used for LSCM experiments (Figures 4c-
d) was treated with elastase at Mre= 8.3. The ThT fluorescence emission of this emulsion was 
characterized by a broad peak centred at 490 nm (results not shown). Figure S9a plots the time 
dependence of the fluorescence emission intensity maximum for 0.05 wt% A9R emulsion, 
stained with ThT (I), normalized by the fluorescence emission maximum for a sample 
containing only ThT (Io). The spectra show a drop in I/Io after 3 hrs due to the breakup of A9R 
fibers induced by the elastase. Simultaneously, the initially homogeneous emulsion (a;  Figure 
S9a) undergoes phase separation (b; Figure S9a).  
Figure S9b shows the time dependence of the CD signal measured for a 0.05 wt% A9R 
emulsion treated with elastase at Mre= 8.3, i.e., the same sample studied in Figure S8a but 
without ThT dye. The CD spectra in Figure S9b show that there is an evolution from a -sheet 
conformation into a disordered secondary structure after 2 days incubation of the emulsion with 
the elastase.  
 
 
 
Conclusions 
We first established that the surfactant-like peptide A9R self-assembles into -sheet fibrils 
above a critical aggregation concentration. X-ray diffraction shows that the -sheets are 
unusually closely spaced due to the tight packing facilitated by the small alanine sequence. 
Remarkably, the peptide forms a self-supporting hydrogel structure without pH adjustment, 
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simply by increasing the concentration sufficiently in water. This is not typical for peptide 
hydrogelation which typically necessitates pH control.60 We believe this is due to the presence 
of only a single charged residue in A9R. Although the termini are uncapped, the location of the 
arginine residue at the C terminus gives rise to a type of “zwitterionic” structure. We 
furthermore established that A9R can be degraded into smaller peptide fragments by the 
enzyme elastase, this being used as the basis to subsequently demonstrate an enzyme-triggered 
de-emulsification process. We next showed that A9R has activity against Gram negative 
bacteria, in particular P. aeruginosa. Gram negative bacterial infections are particularly 
challenging and P. aeruginosa is the source of serious hospital infections and strains have 
evolved antimicrobial resistance.61-63 Our results suggest that peptide A9R has great potential 
in the development of future antibacterial therapeutics based on our initial assays. 
We furthermore hypothesized that A9R, being a surfactant-like peptide, would potentially be 
able to stabilize water/oil emulsions. This indeed proved to be the case and stable emulsions in 
the model system water in 1-bromohexadecane were observed. A combination of CD 
spectroscopy and fluorescent dye staining revealed that the emulsion is stabilized by a coating 
of -sheet fibrils around emulsion droplets. These findings provide evidence for the previously 
unreported formation of stable emulsions by an antimicrobial and surfactant-like peptide. The 
emulsions are distinct from conventional surfactant-stabilized emulsions because the peptides 
form -sheet fibril coatings of the emulsion droplets (Scheme 1), rather than simply forming a 
surfactant monolayer at the interface. They can also be compared protein-stabilized emulsions 
which are a type of Pickering (particle-stabilized) emulsion.39-40 As a further demonstration of 
the utility of SLPs in the development of novel responsive nanomaterials, we showed that it is 
possible to de-emulsify the A9R water-in-oil emulsions using the enzyme elastase. This enzyme 
has a key role in the remodelling of the extracellular matrix (it degrades elastin) and so our 
findings point to the possible future development of wound healing materials with 
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antimicrobial activity. On-demand enzyme-triggered de-emulsification may find other 
applications in the creation of responsive nanomaterials, for example for drug delivery. 
Considering the unique properties of peptides in terms of biofunctionality and biodegradability, 
emulsions and gels of antimicrobial surfactant-like peptides have great promise in the future 
production of formulated personal care and food products. Taken together, our results show 
that A9R has an unprecedented diversity of bionanomaterial properties relevant to such 
applications. 
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Figures and Schemes 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 1. (a) ThT assay for A9R. 1 wt% A9R solution: (b) CD data, (c) FTIR spectra, (d) 
cryo-TEM image and  (e) SAXS data along with fitting of the data.  
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Figure 2. A9R hydrogels: (a) tube inversion test, (b) storage and shear modulus, (c) XRD 
spectra on a dry gel stalk and (d) SAXS and WAXS profiles. The full line in (d) is the fitting 
to the experimental data.  
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Figure 3. (a) Cell viability profiles of A9R solutions. Error bars are SEM (n=3). * = p<0.05, 
**= p<0.01. Survival of 3 bacteria strains without (blue line) and in the presence of 0.05 wt% 
A9R (red dashed line) for (b) S. aureus (c) E.coli and (d) P. aeruginosa. Where CFU =colony 
forming units and the error bars represent the standard error of the mean. * = p<0.05 as assessed 
by the t-test between treated and untreated strains. 
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Figure 4. 0.05 wt% A9R emulsion: (a,b) POM, (c,d)  LCSM and (e) TEM images. (f) CD 
data measured for a 0.05 wt% A9R emulsion and for 0 0.05 wt% A9R sol.  
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Figure 5. (a-d) cryo-SEM images obtained for a 0.05 wt% A9R emulsion.  Fig.5a colorization 
assists the visualization of the fibril coating. The image in (d) is an enlargement of the region 
shown in (c) 
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Scheme 1.  A9R peptide fibers stabilize the 0.05 wt% A9R emulsion by forming a fibrillar mesh 
at the interface of the water droplets. 
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